The Sepsis Timebomb. James Wigfull Critical Care and Anaesthesia Sheffield Teaching Hospitals

Similar documents
Speed is Life but a Sledgehammer Helps Too: Combination Antibiotic Therapy For Septic Shock

Empirical Antibiotic Therapy Combo vs Mono : Best

National Emergency Laparotomy Audit. Help Box Text

Sepsis. Reliability- can we achieve Dr Ron Daniels

DELIRIUM IN SEPSIS. Professor Kevin Rooney: National Clinical Lead for Sepsis Alison Hunter: Improvement Advisor, Sepsis Collaborative

Andrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015

Timing of Vasopressors in Septic Shock: How Soon is Too Soon?

Sepsis the clinical syndrome

MAKING SENSE OF IT ALL AUGUST 17

UPMC Critical Care

SHOULD THERAPEUTIC AGENTS FOR SEPSIS TARGET THE GLYCOCALYX?

HAP/VAP care bundle interventions - a UK approach. Dr R G Masterton NHS Ayrshire & Arran

Inflammatory Statements

Sepsis in primary care. what is good care?

Introduction. Peripheral arterial disease. Hospital inpatient data - 5,498 FCE (2009/10), & 530 deaths in England alone

BIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency

Sepsis: A Medical Emergency

Importance of kinetics of procalcitonin in septic patients. János Fazakas MD, PhD Semmelweis University, Department of Transplantation and Surgery

OHSU. Update in Sepsis

A Perioperative Physician s Perspective. SAAPM 25 th October 2016

Variation in ICU Care: Physician Practice Patterns. Allan Garland, MD, MA Professor of Medicine & Community Health Sciences University of Manitoba

Contraindications to time critical surgery; when not to proceed from the perspective of: The Physician A/Prof Peter Morley

Stuart Murdoch Consultant Intensive Care St. James s University Hospital March 2010

Early Recognition and Timely Management of Sepsis Amid Changes in Definitions

Sepsis and Antimcrobial Stewardship: Are they really mutually Exclusive?

No conflicts of interest to disclose

The Pain of a Fractured Neck of Femur. Ms Fiona Nielsen- Project Lead

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program

Audit of perioperative management of patients with fracture neck of femur

Guess or get it right?

How to make changes in the NHS

Reducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway

Sepsi: nuove definizioni, approccio diagnostico e terapia

Evaluation of Social Science Interventions. A/Prof Daryl Jones

PCT-assisted antibiotic therapy

Hip Fracture (HFR) Measures Document

Standards of excellence

GSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:

Profile of Self-harm Attendances at Accident & Emergency Sheffield Teaching Hospitals

Patient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough

Acute Oncology Martin Eatock Consultant Medical Oncologist NICaN Medical Director

Rapid Response Teams. January 17, Safe Table Webinar

Early Goal-Directed Therapy

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

Introduction of the concept of value in sepsis care

The Experience in Exeter with. hip fracture care. Data For Change

Key Points. Angus DC: Crit Care Med 29:1303, 2001

Educational Workshop

Diagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire

Understand the scope of sepsis morbidity and mortality Identify risk factors that predispose a patient to development of sepsis Define and know the

Implementing a new Orthogeriatric model to improve patient care and outcomes Aiming for Excellence!

SEPSIS & SEPTIC SHOCK

pat hways Medtech innovation briefing Published: 29 November 2016 nice.org.uk/guidance/mib87

Emergency Laparotomy

BREAK 11:10-11:

Fluorescence immunoassay Point of care test Wide range PCT. whole blood. plasma. serum

Outcome of patients with hematologic malignancy admitted to the ICU

Frank Sebat, MD - June 29, 2006

High Intensity Chemotherapy Guidelines for Haematology Patients at ASPH

after acute care (inc. ED)?

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU.

A regional perspective, to improve patient outcomes. Mr Peter F. Burke. Senior Consultant General Surgeon: LRH

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

High Tibial Osteotomy surgery

Life After Sepsis: Post-Sepsis Syndrome. Sepsis Virtual Event July 6, :00 1:00 p.m. CT

Nothing to disclose 9/25/2017

Early-goal-directed therapy and protocolised treatment in septic shock

PUZZLE. EARLY IMPACT ALS Jamie Syrett, MD Director of Prehospital Care Rochester General Health System PUZZLE THINKING OUTSIDE THE BOX! EARLY IMPACT?

PCT-assisted antibiotic therapy

9/25/2017. Nothing to disclose

What is sepsis? RECOGNITION. Sepsis I Know It When I See It 9/21/2017

Deteriorating patients:

BC Sepsis Network Emergency Department Sepsis Guidelines

IDENTIFYING SEPSIS IN THE PREHOSPITAL SETTING

PILOT STUDY PROPOSAL FOR EARLY DISCHARGE OF LOW-RISK NEUTROPENIC PATIENTS

Promoting Innovative Practice

EMU A NEW MODEL OF EMERGENCY CARE FOR THE FRAIL & ELDERLY

Sepsis 3.0: The Impact on Quality Improvement Programs

Emergency thoracic surgery. Tim Batchelor Department of Thoracic Surgery Bristol Royal Infirmary

Wait, is this sepsis?

HE Model for Sepsis POCT

FRAX Based Guidelines: Is a Universal Model Appropriate?

Sepsis care and the new core measures

Escalations of Care The Impact of Delayed Diagnosis of Sepsis and Pneumonia

John Park, MD Assistant Professor of Medicine

CORE STANDARDS STANDARDS USED IN TARN REPORTS

Prof Gavin Perkins Co-Chair ILCOR

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand

Policy Register No: Status: Public. Contributes to Care Quality Commission Outcome 4

Sepsis: What Is It Really?

Disclosures. Objectives. Procalcitonin: Pearls and Pitfalls in Daily Practice

The Oxford AHSN Sepsis Pathway

Sepsis Care and the New Core Measures. Daniel S. Hagg, MD January 15, 2016

SHOCK Susanna Hilda Hutajulu, MD, PhD

SUCCESS IN SEPSIS MORTALITY REDUCTION. Maryanne Whitney RN MSN CNS Improvement Advisor, Cynosure Health HRET HEN AK Webinar

Neutropenic Sepsis Acute General Management and Support. Ernie Marshall Macmillan Consultant in Medical Oncology Clatterbridge Centre for Oncology

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

SURVIVING SEPSIS: Early Management Saves Lives

The Usefulness of Sepsis Biomarkers. Dr Vineya Rai Department of Anesthesiology University of Malaya

Anaesthesia for the Over 75s. Chris Edge

Transcription:

The Sepsis Timebomb James Wigfull Critical Care and Anaesthesia Sheffield Teaching Hospitals

Relationship of SIRS, Sepsis and Infection BACTEREMIA PANCREATITIS INFECTION FUNGEMIA PARASITEMIA VIREMIA SEPSIS SIRS POST-PUMP SYNDROME TRAUMA BURNS OTHER OTHER The ACCP/SCCM consensus Conference Committee, Chest 1992;101:1644-55.

Sepsis and mortality Vallés et al. Chest 2003;123:1615 1624

Sepsis and Septic Shock: An Intensivist s Immunologic View Antimicrobials Infection CARS SIRS Organ Injury Antiinflammatory (endogenous) Time RECOVERY van der Poll T, van Deventer SJH. Infect Dis Clin N Am

Sepsis and Septic Shock: An ID View Cellular dysfunction/tissue injury Inflammatory response Shock Threshold Toxic burden Microbial load TIME

An Injury Paradigm of Sepsis and Septic Shock Prof A Kumar, University of Manitoba Antimicrobial therapy Cellular dysfunction/tissue injury Inflammatory response Shock Threshold Toxic burden Microbial load TIME

An Injury Paradigm of Sepsis and Septic Shock Prof A Kumar, University of Manitoba earlier antimicrobial therapy Cellular dysfunction/tissue injury Shock Threshold Inflammatory response Toxic burden Microbial load TIME

An Injury Paradigm of Sepsis and Septic Shock Prof A Kumar, University of Manitoba Antimicrobial therapy + Source control Cellular dysfunction/tissue injury Shock Threshold Inflammatory response Toxic burden Microbial load TIME

fraction of total patients Cumulative Initiation of Effective Antimicrobial Therapy and Survival in Septic Shock 1.0 survival fraction cumulative antibiotic initiation 0.8 0.6 0.4 0.2 0.0 time from hypotension onset (hrs) Kumar et al. CCM. 2006:34:1589-96.

Odds Ratio of Death (95% Confidence Interval) Mortality Risk with Increasing Delays in Initiation of Effective Antimicrobial Therapy 100 10 1 Kumar et al, CCM. 2006:34:1589-96. Time (hrs)

Comparison with other time dependent interventions NNT NNT MI 30 CVA 30-40 Trauma 30 Severe sepsis Septic shock 6-8 Easy diagnosis Clear onset Presents to A&E Not recognized early Insidious onset Often develops on wards

Door to balloon time and mortality in AMI Adapted from Cannon et al. JAMA 2000; 283: 2941-7.

"Preventable" deaths per year Door to balloon time and mortality in AMI 1600 1400 1200 By getting door-to-balloon times of 1000 <2h for ALL STEMI patients, 800 we would save 600 4775 lives per year. 400 200 0 0-2h >2-3h >3-4h >4-6h >6-12h >12h "Preventable deaths" 0 282 1350 1555 1384 204 Adapted from Cannon et al. JAMA 2000; 283: 2941-7.

Percentage of patients Shock to effective antibiotic time and mortality in septic shock 90 80 70 60 50 40 30 20 10 0 0-2h >2-3h >3-4h >4-6h >6-12h >12h %Mortality 26.7 36.1 36.6 46.8 62.3 83.1 % of patients 26.8 9.0 7.8 12.8 18.8 24.9 Adapted from Kumar et al. Crit Care Med 2006; 34: 1589-96.

"Preventable" deaths per year Shock to effective antibiotic time and mortality in septic shock 20000 18000 16000 By getting 14000 shock-to-antibiotic times of <2h for ALL septic shock patients, we would save 32,360 lives per year. 12000 10000 8000 6000 4000 2000 0 0-2h >2-3h >3-4h >4-6h >6-12h >12h "Preventable" Deaths 0 1093 1000 3318 8710 18239 Adapted from Kumar et al. Crit Care Med 2006; 34: 1589-96.

72 83 50 35 26 18 Ab s given

Effect of Failure to Implement Source Control if Required 100 80 60 % total patients % survival 40 20 0 Source Control Implemented Source Control Not Implemented

fraction of total patients Cumulative Source Control Implementation and Survival in Septic Shock 1.0 survival fraction cumulative source control implementation 0.8 0.6 0.4 0.2 0.0 time from hypotension onset (hrs)

Source Control/Antimicrobial Interaction and Survival in Septic Shock Antimicrobial Initiation Post-Shock < 3 h 3-6 h > 6 h < 6 h 92% (n=75) 70.3% (n=37) 44.4% (n=63) Source Control Initiation Post-Shock 6-24 h 80.0% (n=60) 46.0% (n=50) 19.0% (n=94) > 24 h 69.0% (n=29) 36.0% (n=25) 13.0% (n=100)

22 30 83 83 78 78 72 72 60 46% Ab s given Source control

hours Audit of Event timing from SHEWS 2 to theatre for the deteriorating colorectal patient at NGH from October 2009 to March 2010 9 8 7 6 5 4 3 2 1 0 A B C D E F A: SHEWS 2 to SpR review B: SpR review to Antibiotics C: CT booking to scan D: CTscan to report E: Scan to theatre booking F: Booking to arrival

Audit of Event timing from SHEWS 2 to theatre for the deteriorating colorectal patient at NGH from October 2009 to March 2010 25 20 15 10 5 Total time from trigger to theatre 0 Survivors Nonsurvivors

The Size Of The Problem 170 000 patients per year in the UK receive higher risk emergency general surgery 100 000 will develop significant complications Resulting in 25000 deaths

Number of ITU beds by country 0 5 10 15 20 25 30 Germany Belgium Croatia USA Canada France Netherlands Spain Australia New Zealand China UK Series1 Series2 ITU beds per 100000 population ITU beds per 100 acute hospital beds

Key recommendations

Key recommendations

Key recommendations

Key recommendations

Key recommendations

The National Emergency Laparotomy Audit Dave Murray National Clinical Lead www.nela.org.uk info@nela.org.uk

Audit against standards

Key Recommendations: Delivery of Care Patient Pathway: Clear diagnostic and monitoring plans Adoption of escalation strategy with early involvement of senior staff Timing of diagnostic tests / timing of surgery Adequate emergency theatre access with appropriate prioritisation Post-operative location Risk of death estimated and documented: prior to surgery to ensure adjustments made in urgency of care and seniority of staff involved at end of surgery to determine optimal location for post-operative care

Key Recommendations: Individualised care High risk patients 10% 30d mortality Two consultants in theatre (surgeon and anaesthetist) Post-op Critical Care Unit Elderly patients Specialist input pre- and post-op Nutrition

The role of Outcome Measures in improving quality of care 30-day mortality Risk adjusted via P-POSSUM Unplanned return to theatre escalation of care 30-day readmission

The role of Process Measures in improving quality of care Admission to first dose of antibiotics Time from decision to theatre Pre-op CT scan Objective assessment of risk of death High risk patients directly admitted to critical care post-op Key Standards of Care relate to patient s predicted risk of death

Conclusions With the onset of shock the mortality clock starts ticking! Timely delivery of appropriate antibiotics is everybody s responsibility deal with it if it hasn t already happened Source control the mortality clock does not wait for a convenient theatre slot